Suppr超能文献

局部眼降压药物冲洗后眼压变化。

Intraocular pressure changes following topical ocular hypotensive medications washout.

机构信息

Department of Ophthalmology, St. Thomas' Hospital, London, UK.

KCL Frost Eye Research Department, King's College London, London, UK.

出版信息

Br J Ophthalmol. 2021 Feb;105(2):205-209. doi: 10.1136/bjophthalmol-2019-315778. Epub 2020 Apr 10.

Abstract

BACKGROUND

To review the changes in intraocular pressure (IOP) following topical hypotensive medications washout in patients with primary open angle glaucoma (POAG), ocular hypertension (OHT) and uveitic glaucoma (UG)/OHT.

METHODS

The study included 120 patients with POAG, OHT and UG recruited from prospective clinical trials between February 2013 and July 2017. We excluded 20 eyes with IOP of ≤21 mm Hg, 11 eyes with previous incisional surgery and 17 eyes with incomplete data. UG eyes with active inflammation and on steroid treatment were excluded. Participants underwent a 1-month washout period from topical ocular hypotensive medications before IOP phasing. Comparisons were made between pre/post-washout IOP, and highest-recorded (peak) and post-washout IOP.

RESULTS

A total of 110 eyes with POAG, 33 eyes with OHT and 43 eyes with UG were included for analysis. The mean pre-washout IOP was 18.1±3.3 mm Hg in POAG, 18.8±3.3 mm Hg in OHT and 17.9±8.8 mm Hg in UG; the mean post-washout IOP was 26.6±4.8 mm Hg, 26.4±3.9 mm Hg, 23.1±10.1 mm Hg in POAG, OHT and UG, respectively. The mean increase in IOP after washout was significantly lower in UG compared with POAG and OHT eyes (p=0.01). The percentage of eyes with post-washout IOP <22 mm Hg was 12.7% in POAG, 6.1% in OHT and 51.2% in UG.

CONCLUSION

Active inflammation and steroid treatment contributes to elevated IOP in uveitis. Therefore, IOP may revert to normal once inflammation subsides. We recommend ocular hypotensive treatment washout to be considered in UG eyes that have IOP under control in the absence of recurrence of uveitis.

摘要

背景

本研究旨在评估原发性开角型青光眼(POAG)、高眼压症(OHT)和葡萄膜炎性青光眼(UG)/OHT 患者停用局部降眼压药物后眼内压(IOP)的变化。

方法

本研究纳入了 2013 年 2 月至 2017 年 7 月前瞻性临床试验中招募的 120 例 POAG、OHT 和 UG 患者。排除了 IOP≤21mmHg 的 20 只眼、既往有切口手术的 11 只眼和数据不完整的 17 只眼。排除活动性炎症且正在接受类固醇治疗的 UG 眼。所有患者在 IOP 分相前进行为期 1 个月的局部眼部降眼压药物洗脱期。比较洗脱前后的 IOP、最高记录(峰值)和洗脱后的 IOP。

结果

共纳入 110 只 POAG 眼、33 只 OHT 眼和 43 只 UG 眼进行分析。POAG 患者的平均预洗脱 IOP 为 18.1±3.3mmHg,OHT 患者为 18.8±3.3mmHg,UG 患者为 17.9±8.8mmHg;POAG、OHT 和 UG 患者的平均洗脱后 IOP 分别为 26.6±4.8mmHg、26.4±3.9mmHg 和 23.1±10.1mmHg。与 POAG 和 OHT 眼相比,UG 眼洗脱后 IOP 的平均升高明显较低(p=0.01)。POAG 眼、OHT 眼和 UG 眼中,洗脱后 IOP<22mmHg 的眼比例分别为 12.7%、6.1%和 51.2%。

结论

活动性炎症和类固醇治疗可导致葡萄膜炎患者的 IOP 升高。因此,一旦炎症消退,IOP 可能恢复正常。我们建议在没有葡萄膜炎复发的情况下,将眼压控制在正常范围内的 UG 眼停用眼部降眼压药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验